Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anderson H, Hopwood P, Stephens RJ, Thatcher N, Cottier B, Nicolson M, Milroy R, Maughan TS, Falk S, Bond MG, Burt PA, Connolly CK, McIllmurray MB and Carmichael J on behalf of the UK NSCLC Gemcitabine Group (2000) Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomised trial with quality of life as the primary outcome. Brit J Cancer 83: 447–453
Ball D, Borland R, Smith J, Bishop J, O’Brien P, Davis S, Olver I, Walker Q, Ryan G and Joseph D (2000) The influence of pre-treatment optimism on outcome in patients given radical radiotherapy for non-small cell lung cancer. Lung Cancer 29: 173, abst 585
Cullen MH, Billingham LJ, Woodroffe CM, Chetiyawardana AD, Gower NH, Joshi R, Ferry DR, Rudd RM, Spiro SG, Cook JE, Trask C, Bessell E, Connolly CK, Tobias J and Souhami RL (1999) Mitomycin, ifosfamide and cisplatin in unresectable non small cell lung cancer: effects on survival and quality of life. J Clin Oncol 17: 3188–3194
Marino P, Pampallona S, Preatoni A, Cantoni A and Invernizzi F (1994) Chemotherapy vs supportive care in advanced non small cell lung cancer. Results of a meta-analysis of the literature. Chest 106: 861–865
Non Small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trails. BMJ 311: 899–909
Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, Lopez P, Anderson H, Gustafson N, Jeynes A, Gallant G, Washington T and Thatcher N (2000) Randomised trial of paclitaxel plus best supportive care versus best supportive care for patients with advanced non small cell lung cancer. J Natl Cancer Inst 92: 1074–1080
Roszkowski K, Pluzanska A, Krzakowski M, Smith AP, Saigi E, Aasebo U, Parisi A, Tran NP, Olivares R and Berille J (2000) A multicentre, randomised, phase III study of docetaxel plus best supportive care in chemotherapy naive patients with metastatic or nonresectable localised non small cell lung cancer. Lung Cancer 27: 145–147
Schiller JH, Harrington D, Sandler A, Belani C, Langer C, Krook J and Johnson DH (2000) A randomised phase III trial of four chemotherapy regimens in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 19: abst 2
Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y and Ganz PA (1993) Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 342: 19–21
The elderly lung cancer vinorelbine Italian study group (1999) Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 91: 66–72
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Anderson, H., Carmichael, J., Nicolson, M. et al. Chemotherapy and quality of life in advanced NSCLC – reply. Br J Cancer 85, 137–138 (2001). https://doi.org/10.1054/bjoc.2001.1852
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1852